US: IDE (investigational device exemption) does not necessarily equal national coverage
This article was originally published in Clinica
Executive Summary
An FDA investigational device exemption for a product does not automatically guarantee nationwide coverage for the product, a local Medicare carrier warned last week. Saty Satya-Murti, Medicare medical director for Blue Cross and Blue shield of Kansas, says there are times when local carriers choose not to cover such investigational products.